Ted Slafsky

Background

About Ted Slafsky

National expert & thought leader on health care access and drug pricing. Publisher & CEO of 340B Report, the only news service focused exclusively on the federal 340B drug discount program. 340B Report is the indispensable source for 340B news and information. Thousands of 340B stakeholders throughout the supply chain and the government rely on 340B Report.Founder and Principal of Wexford Solutions, a small health care consulting firm. Write montly thought leader column and speak through the country on matters related to the 340B program and drug pricing.Frequently quoted in national news publications. One of the nation’s leading experts on pharmaceutical and health care matters impacting low-income and other vulnerable patients. Publish op-eds in various national publications including USA Today, Health Affairs, STAT & The Hill. Served as President/CEO of 340B Health, association of 340B hospitals Led organization from 2007-2018 and served in senior positions for over two decades. Responsible for growing the organization from 50 to over 1300 hospitals. Started innovative corporate partner program that includes over 60 companies including several Fortune 100 firms.Oversaw team of government relations experts, attorneys and pharmacists who advocate on behalf of hospitals and provide compliance guidance. Responsible for overseeing a number of conferences and meetings on improving access to pharmaceutical care and ensuring compliance with drug pricing laws. Grew conferences from less than 100 attendees to over 1500 per event.Reporter-researcher at U.S. News and World Report. Provided editorial assistance to David Gergen, Editor-at-Large and advisor to four U.S. presidents. Wrote and researched articles on health, education and other policy areas. Health policy fellow in U.S. Senate.